{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:27:38Z","timestamp":1787509658160,"version":"build-2736575974"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85887-2","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T03:39:29Z","timestamp":1736998769000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Comprehensive investigation of matrix metalloproteinases in skin cutaneous melanoma: diagnostic, prognostic, and therapeutic insights"],"prefix":"10.1038","volume":"15","author":[{"given":"Lingxia","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxiaoxiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weicai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"85887_CR1","doi-asserted-by":"crossref","unstructured":"Yue, C. et al. Reactive oxygen species profiles reveal the tumor immune micro-environment and clinical outcomes of skin cutaneous melanoma (2023).","DOI":"10.21203\/rs.3.rs-3319077\/v1"},{"issue":"1","key":"85887_CR2","doi-asserted-by":"publisher","first-page":"21094","DOI":"10.1038\/s41598-023-48374-0","volume":"13","author":"B Yang","year":"2023","unstructured":"Yang, B., Xie, P., Huai, H. & Li, J. Comprehensive analysis of necroptotic patterns and associated immune landscapes in individualized treatment of skin cutaneous melanoma. Sci. Rep. 13(1), 21094 (2023).","journal-title":"Sci. Rep."},{"issue":"1","key":"85887_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.62347\/TWOY1681","volume":"16","author":"MA Abdel-Maksoud","year":"2024","unstructured":"Abdel-Maksoud, M. A. et al. Unlocking the diagnostic, prognostic roles, and immune implications of BAX gene expression in pan-cancer analysis. Am. J. Transl Res. 16(1), 63 (2024).","journal-title":"Am. J. Transl Res."},{"issue":"1","key":"85887_CR4","doi-asserted-by":"publisher","first-page":"e3644","DOI":"10.1002\/jgm.3644","volume":"26","author":"X Jia","year":"2024","unstructured":"Jia, X. et al. HGF facilitates methylation of MEG3, potentially implicated in vemurafenib resistance in melanoma. J. Gene Med. 26(1), e3644 (2024).","journal-title":"J. Gene Med."},{"key":"85887_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev-pathol-042320-120056","volume":"17","author":"MS Chang","year":"2022","unstructured":"Chang, M. S., Azin, M. & Demehri, S. Cutaneous squamous cell carcinoma: the frontier of cancer immunoprevention. Annu. Rev. Pathol. Mech. Dis. 17, 101\u2013119 (2022).","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"1","key":"85887_CR6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.hoc.2018.09.005","volume":"33","author":"RI Hartman","year":"2019","unstructured":"Hartman, R. I. & Lin, J. Y. Cutaneous melanoma\u2014a review in detection, staging, and management. Hematol. Oncol. Clin. 33(1), 25\u201338 (2019).","journal-title":"Hematol. Oncol. Clin."},{"issue":"5","key":"85887_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.3390\/cells9051313","volume":"9","author":"M Raeeszadeh-Sarmazdeh","year":"2020","unstructured":"Raeeszadeh-Sarmazdeh, M., Do, L. D. & Hritz, B. G. Metalloproteinases and their inhibitors: potential for the development of new therapeutics. Cells 9(5), 1313 (2020).","journal-title":"Cells"},{"key":"85887_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2018.08.007","volume":"75","author":"NK Karamanos","year":"2019","unstructured":"Karamanos, N. K., Theocharis, A. D., Neill, T. & Iozzo, R. V. Matrix modeling and remodeling: a biological interplay regulating tissue homeostasis and diseases. Matrix Biol. 75, 1\u201311 (2019).","journal-title":"Matrix Biol."},{"issue":"11","key":"85887_CR9","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/bjc.1996.266","volume":"73","author":"A Kossakowska","year":"1996","unstructured":"Kossakowska, A., Huchcroft, S., Urbanski, S. & Edwards, D. Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-hodgkin\u2019s lymphomas in humans. Br. J. Cancer 73(11), 1401\u20131408 (1996).","journal-title":"Br. J. Cancer"},{"issue":"2","key":"85887_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/sj.bjc.6690689","volume":"81","author":"EA Garbett","year":"1999","unstructured":"Garbett, E. A., Reed, M. & Brown, N. Proteolysis in human breast and colorectal cancer. Br. J. Cancer. 81(2), 287\u2013293 (1999).","journal-title":"Br. J. Cancer"},{"issue":"3","key":"85887_CR11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1399-0004.2007.00946.x","volume":"73","author":"J Decock","year":"2008","unstructured":"Decock, J., Paridaens, R. & Ye, S. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin. Genet. 73(3), 197\u2013211 (2008).","journal-title":"Clin. Genet."},{"key":"85887_CR12","doi-asserted-by":"crossref","unstructured":"Khan, M. & Hameed, Y. Discovery of novel six genes-based cervical cancer-associated biomarkers that are capable to break the heterogeneity barrier and applicable at the global level. J. Cancer Res. Ther. (2023).","DOI":"10.4103\/jcrt.jcrt_1588_21"},{"issue":"4","key":"85887_CR13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","volume":"21","author":"TR Cox","year":"2021","unstructured":"Cox, T. R. The matrix in cancer. Nat. Rev. Cancer 21(4), 217\u2013238 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"85887_CR14","doi-asserted-by":"publisher","first-page":"101824","DOI":"10.1016\/j.tranon.2023.101824","volume":"39","author":"B Chen","year":"2024","unstructured":"Chen, B. et al. Fam198b as a novel biomarker for gastric cancer and a potential therapeutic target to prevent tumor cell proliferation dysregulation. Transl.  Oncol. 39, 101824 (2024).","journal-title":"Transl. Oncol."},{"key":"85887_CR15","doi-asserted-by":"crossref","unstructured":"Ratnikov, B. I. et al. Basis for substrate recognition and distinction by matrix metalloproteinases. Proc. Natl. Acad. Sci. 111(40), E4148\u2013E4155 (2014).","DOI":"10.1073\/pnas.1406134111"},{"issue":"5","key":"85887_CR16","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.ceb.2009.06.006","volume":"21","author":"CJ Morrison","year":"2009","unstructured":"Morrison, C. J., Butler, G. S., Rodr\u00edguez, D. & Overall, C. M. Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr. Opin. Cell Biol. 21(5), 645\u2013653 (2009).","journal-title":"Curr. Opin. Cell Biol."},{"key":"85887_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3389\/fonc.2019.01370","volume":"9","author":"S Quintero-Fabi\u00e1n","year":"2019","unstructured":"Quintero-Fabi\u00e1n, S. et al. Role of matrix metalloproteinases in angiogenesis and cancer. Front. Oncol. 9, 1370 (2019).","journal-title":"Front. Oncol."},{"key":"85887_CR18","doi-asserted-by":"publisher","first-page":"928315","DOI":"10.1155\/2013\/928315","volume":"2013","author":"Q Chen","year":"2013","unstructured":"Chen, Q. et al. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat. Inflamm. 2013, 928315 (2013).","journal-title":"Mediat. Inflamm."},{"issue":"sup1","key":"85887_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3109\/14756366.2016.1161620","volume":"31","author":"A Jab\u0142o\u0144ska-Trypu\u0107","year":"2016","unstructured":"Jab\u0142o\u0144ska-Trypu\u0107, A., Matejczyk, M. & Rosochacki, S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J. Enzyme Inhib. Med. Chem. 31(sup1), 177\u2013183 (2016).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"85887_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s10555-010-9235-2","volume":"29","author":"SC Gupta","year":"2010","unstructured":"Gupta, S. C., Kim, J. H., Prasad, S. & Aggarwal, B. B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29, 405\u2013434 (2010).","journal-title":"Cancer Metastasis Rev."},{"key":"85887_CR21","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_1901_20","author":"M Usman","year":"2023","unstructured":"Usman, M. & Hameed, Y. GNB1, a novel diagnostic and prognostic potential biomarker of head and neck and liver hepatocellular carcinoma. J. Cancer Res. Ther. https:\/\/doi.org\/10.4103\/jcrt.jcrt_1901_20 (2023).","journal-title":"J. Cancer Res. Ther."},{"issue":"3","key":"85887_CR22","first-page":"2591","volume":"16","author":"Y Dong","year":"2024","unstructured":"Dong, Y. et al. Prognostic model development and molecular subtypes identification in bladder urothelial cancer by oxidative stress signatures. Aging (Albany NY) 16(3), 2591 (2024).","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"85887_CR23","doi-asserted-by":"publisher","first-page":"432","DOI":"10.62347\/WSEF7878","volume":"16","author":"H Hu","year":"2024","unstructured":"Hu, H. et al. CDCA8, a mitosis-related gene, as a prospective pan-cancer biomarker: implications for survival prognosis and oncogenic immunology. Am. J. Transl Res. 16 (2), 432 (2024).","journal-title":"Am. J. Transl Res."},{"key":"85887_CR24","doi-asserted-by":"publisher","DOI":"10.2174\/1566524023666220819124419","author":"Y Hameed","year":"2022","unstructured":"Hameed, Y., Ahmad, M., Ejaz, S. & Liang, S. Identification of key biomarkers for the future applications in diagnostics and targeted therapy of colorectal cancer. Curr. Mol. Med. https:\/\/doi.org\/10.2174\/1566524023666220819124419 (2022).","journal-title":"Curr. Mol. Med."},{"issue":"7","key":"85887_CR25","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.4103\/jcrt.jcrt_1902_21","volume":"19","author":"Y Hameed","year":"2023","unstructured":"Hameed, Y. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses. J. Cancer Res. Ther. 19(7), 1852\u20131864 (2023).","journal-title":"J. Cancer Res. Ther."},{"issue":"2","key":"85887_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5301\/JBM.5000026","volume":"28","author":"W Li","year":"2013","unstructured":"Li, W., Saji, S., Sato, F., Noda, M. & Toi, M. Potential clinical applications of matrix metalloproteinase inhibitors and their future prospects. Int. J. Biol. Mark. 28(2), 117\u2013130 (2013).","journal-title":"Int. J. Biol. Mark."},{"issue":"12","key":"85887_CR27","doi-asserted-by":"publisher","first-page":"7782","DOI":"10.1021\/acs.chemrev.2c00915","volume":"123","author":"L Qian","year":"2023","unstructured":"Qian, L. et al. The dawn of a new era: targeting the undruggables with antibody-based therapeutics. Chem. Rev. 123(12), 7782\u20137853 (2023).","journal-title":"Chem. Rev."},{"key":"85887_CR28","doi-asserted-by":"publisher","first-page":"1403021","DOI":"10.3389\/fmolb.2024.1403021","volume":"11","author":"C Sorino","year":"2024","unstructured":"Sorino, C., Iezzi, S., Ciuffreda, L. & Falcone, I. Immunotherapy in melanoma: advances, pitfalls, and future perspectives. Front. Mol. Biosci. 11, 1403021 (2024).","journal-title":"Front. Mol. Biosci."},{"issue":"W1","key":"85887_CR29","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T. & Zhang, Z. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 47(W1), W556\u2013W60 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"85887_CR30","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/pro.3307","volume":"27","author":"PJ Thul","year":"2018","unstructured":"Thul, P. J. & Lindskog, C. The human protein atlas: a spatial map of the human proteome. Protein Sci. 27(1), 233\u2013244 (2018).","journal-title":"Protein Sci."},{"issue":"1","key":"85887_CR31","doi-asserted-by":"publisher","first-page":"015","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"A Koch","year":"2015","unstructured":"Koch, A., De Meyer, T., Jeschke, J. & Van Criekinge, W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genom. 16(1), 015\u20131847 (2015).","journal-title":"BMC Genom."},{"issue":"5","key":"85887_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2(5), 401\u2013404 (2012).","journal-title":"Cancer Discov"},{"issue":"W1","key":"85887_CR33","doi-asserted-by":"publisher","first-page":"W244","DOI":"10.1093\/nar\/gkaa467","volume":"48","author":"L Chang","year":"2020","unstructured":"Chang, L., Zhou, G., Soufan, O. & Xia, J. miRNet 2.0: network-based visual analytics for miRNA functional analysis and systems biology. Nucleic Acids Res. 48(W1), W244\u2013W51 (2020).","journal-title":"Nucleic Acids Res."},{"issue":"20","key":"85887_CR34","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","volume":"35","author":"B Ru","year":"2019","unstructured":"Ru, B. et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics 35(20), 4200\u20134202 (2019).","journal-title":"Bioinformatics"},{"key":"85887_CR35","doi-asserted-by":"crossref","unstructured":"Liu, C. J. et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief. Bioinform. 24(1) (2023).","DOI":"10.1093\/bib\/bbac558"},{"issue":"D1","key":"85887_CR36","doi-asserted-by":"publisher","first-page":"D900","DOI":"10.1093\/nar\/gky939","volume":"47","author":"H Yuan","year":"2019","unstructured":"Yuan, H. et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 47(D1), D900\u2013D908 (2019).","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"85887_CR37","doi-asserted-by":"publisher","first-page":"e0122316","DOI":"10.1371\/journal.pone.0122316","volume":"10","author":"S Soleyman-Jahi","year":"2015","unstructured":"Soleyman-Jahi, S. et al. Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PLoS One. 10(4), e0122316 (2015).","journal-title":"PLoS One"},{"key":"85887_CR38","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s00384-009-0725-z","volume":"24","author":"Y Fang","year":"2009","unstructured":"Fang, Y. et al. Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int. J. Colorectal Dis. 24, 875\u2013884 (2009).","journal-title":"Int. J. Colorectal Dis."},{"issue":"5","key":"85887_CR39","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3892\/ijo.2016.3400","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang, X. et al. Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics. Int. J. Oncol. 48(5), 1783\u20131793 (2016).","journal-title":"Int. J. Oncol."},{"issue":"1","key":"85887_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/ijms23010146","volume":"23","author":"S Niland","year":"2021","unstructured":"Niland, S., Riscanevo, A. X. & Eble, J. A. Matrix metalloproteinases shape the tumor microenvironment in cancer progression. Int. J. Mol. Sci. 23(1), 146 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"85887_CR41","doi-asserted-by":"publisher","first-page":"1471267","DOI":"10.3389\/fonc.2024.1471267","volume":"14","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Identification and validation of matrix metalloproteinase hub genes as potential biomarkers for skin cutaneous melanoma. Front. Oncol. 14, 1471267 (2024).","journal-title":"Front. Oncol."},{"key":"85887_CR42","doi-asserted-by":"publisher","first-page":"717606","DOI":"10.3389\/fonc.2021.717606","volume":"11","author":"M Li","year":"2021","unstructured":"Li, M. et al. Immune infiltration of MMP14 in pan cancer and its prognostic effect on tumors. Front. Oncol. 11, 717606 (2021).","journal-title":"Front. Oncol."},{"issue":"2","key":"85887_CR43","first-page":"158","volume":"14","author":"C Gebhardt","year":"2016","unstructured":"Gebhardt, C., Lichtenberger, R. & Utikal, J. Biomarker value and pitfalls of serum S100B in the follow-up of high\u2010risk melanoma patients. JDDG: J. Der Deutschen Dermatologischen Gesellschaft 14(2), 158\u2013164 (2016).","journal-title":"JDDG: J. Der Deutschen Dermatologischen Gesellschaft"},{"issue":"4","key":"85887_CR44","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00403-022-02425-0","volume":"315","author":"AD Desai","year":"2023","unstructured":"Desai, A. D. et al. An analysis of lactate dehydrogenase (LDH) levels in advanced stage IV melanoma of the skin: prognostic capabilities and demographic variability. Arch. Dermatol. Res. 315(4), 799\u2013806 (2023).","journal-title":"Arch. Dermatol. Res."},{"issue":"10","key":"85887_CR45","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1200\/JCO.23.01020","volume":"42","author":"AH Varey","year":"2024","unstructured":"Varey, A. H. et al. Predicting recurrence-free and overall survival for patients with stage II melanoma: the MIA calculator. J. Clin. Oncol. 42(10), 1169\u20131180 (2024).","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"85887_CR46","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1080\/21655979.2021.1933743","volume":"12","author":"J Zhang","year":"2021","unstructured":"Zhang, J. et al. Identification of TYR, TYRP1, DCT and LARP7 as related biomarkers and immune infiltration characteristics of vitiligo via comprehensive strategies. Bioengineered 12(1), 2214\u20132227 (2021).","journal-title":"Bioengineered"},{"issue":"13","key":"85887_CR47","doi-asserted-by":"publisher","first-page":"11619","DOI":"10.1007\/s00432-023-05064-8","volume":"149","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma. J. Cancer Res. Clin. Oncol. 149(13), 11619\u201311634 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"85887_CR48","doi-asserted-by":"publisher","first-page":"882431","DOI":"10.3389\/fendo.2022.882431","volume":"13","author":"L Liang","year":"2022","unstructured":"Liang, L., Mai, S., Mai, G., Chen, Y. & Liu, L. DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma. Front. Endocrinol. 13, 882431 (2022).","journal-title":"Front. Endocrinol."},{"key":"85887_CR49","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/PGPM.S310299","volume":"14","author":"S Ping","year":"2021","unstructured":"Ping, S., Wang, S., He, J. & Chen, J. Identification and validation of immune-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Pharmacogenomics Person Med. 14, 667\u2013681 (2021).","journal-title":"Pharmacogenomics Person Med."},{"key":"85887_CR50","doi-asserted-by":"publisher","first-page":"758981","DOI":"10.3389\/fgene.2021.758981","volume":"12","author":"Z Xu","year":"2021","unstructured":"Xu, Z. et al. Ferroptosis-related gene signature predicts the prognosis of skin cutaneous melanoma and response to immunotherapy. Front. Genet. 12, 758981 (2021).","journal-title":"Front. Genet."},{"issue":"4","key":"85887_CR51","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1002\/ddr.21515","volume":"80","author":"XH Gao","year":"2019","unstructured":"Gao, X. H., Tang, J. J., Liu, H. R., Liu, L. B. & Liu, Y. Z. Structure\u2013activity study of fluorine or chlorine-substituted cinnamic acid derivatives with tertiary amine side chain in acetylcholinesterase and butyrylcholinesterase inhibition. Drug Dev. Res. 80(4), 438\u2013445 (2019).","journal-title":"Drug Dev. Res."},{"issue":"4","key":"85887_CR52","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"WW Duan","year":"2024","unstructured":"Duan, W. W. et al. A TGF-\u03b2 signaling\u2010related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci. Ther. 30(4), e14489 (2024).","journal-title":"CNS Neurosci. Ther."},{"key":"85887_CR53","doi-asserted-by":"crossref","unstructured":"Wang, Y. et al. Tumor cell-targeting and tumor microenvironment\u2013responsive nanoplatforms for the multimodal imaging-guided photodynamic\/photothermal\/chemodynamic treatment of cervical cancer. Int. J. Nanomed., 5837\u20135858 (2024).","DOI":"10.2147\/IJN.S466042"},{"key":"85887_CR54","doi-asserted-by":"publisher","DOI":"10.1177\/01455613241228211","author":"M Liu","year":"2024","unstructured":"Liu, M. et al. The trajectory of oral mucositis in head and neck cancer patients undergoing radiotherapy and its influencing factors. Ear Nose Throat J. https:\/\/doi.org\/10.1177\/01455613241228211 (2024).","journal-title":"Ear Nose Throat J."},{"issue":"4","key":"85887_CR55","doi-asserted-by":"publisher","first-page":"044002","DOI":"10.1117\/1.APN.2.4.044002","volume":"2","author":"X Hu","year":"2023","unstructured":"Hu, X., Zhou, L., Wu, X. & Peng, Y. Review on near-field detection technology in the biomedical field. Adv. Photonics Nexus. 2(4), 044002 (2023).","journal-title":"Adv. Photonics Nexus"},{"issue":"14","key":"85887_CR56","doi-asserted-by":"publisher","first-page":"11162","DOI":"10.18632\/aging.205952","volume":"16","author":"J Dai","year":"2024","unstructured":"Dai, J., Gao, J. & Dong, H. Prognostic relevance and validation of ARPC1A in the progression of low-grade glioma. Aging (Albany NY). 16(14), 11162 (2024).","journal-title":"Aging (Albany NY)"},{"key":"85887_CR57","doi-asserted-by":"publisher","first-page":"155460","DOI":"10.1016\/j.prp.2024.155460","volume":"260","author":"Z Guo","year":"2024","unstructured":"Guo, Z., Guan, K., Bao, M., He, B. & Lu, J. LINC-PINT plays an anti-tumor role in nasopharyngeal carcinoma by binding to XRCC6 and affecting its function. Pathol. Res. Pract. 260, 155460 (2024).","journal-title":"Pathol. Res. Pract."},{"key":"85887_CR58","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.biopha.2017.08.120","volume":"95","author":"M Hu","year":"2017","unstructured":"Hu, M. et al. IL-1\u03b2-induced NF-\u03baB activation down-regulates miR-506 expression to promotes osteosarcoma cell growth through JAG1. Biomed.  Pharmacother. 95, 1147\u20131155 (2017).","journal-title":"Biomed. Pharmacother."},{"issue":"19","key":"85887_CR59","doi-asserted-by":"publisher","first-page":"4947","DOI":"10.3390\/ijms20194947","volume":"20","author":"M Paolillo","year":"2019","unstructured":"Paolillo, M. & Schinelli, S. Extracellular matrix alterations in metastatic processes. Int. J. Mol. Sci. 20(19), 4947 (2019).","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"85887_CR60","doi-asserted-by":"publisher","first-page":"119103","DOI":"10.1016\/j.bbamcr.2021.119103","volume":"1868","author":"A Ansardamavandi","year":"2021","unstructured":"Ansardamavandi, A. & Tafazzoli-Shadpour, M. The functional cross talk between cancer cells and cancer associated fibroblasts from a cancer mechanics perspective. Biochim. Biophys. Acta (BBA)-Mol. Cell Res. 1868(11), 119103 (2021).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Cell Res."},{"issue":"344","key":"85887_CR61","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M. & Medici, D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci. Signal. 7(344), re8\u2013re (2014).","journal-title":"Sci. Signal."},{"key":"85887_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fonc.2018.00431","volume":"8","author":"V Poltavets","year":"2018","unstructured":"Poltavets, V., Kochetkova, M., Pitson, S. M. & Samuel, M. S. The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Front. Oncol. 8, 431 (2018).","journal-title":"Front. Oncol."},{"issue":"2","key":"85887_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","volume":"9","author":"JE Rundhaug","year":"2005","unstructured":"Rundhaug, J. E. Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med. 9(2), 267\u2013285 (2005).","journal-title":"J. Cell. Mol. Med."},{"issue":"24","key":"85887_CR64","doi-asserted-by":"publisher","first-page":"17536","DOI":"10.3390\/ijms242417536","volume":"24","author":"K Baghy","year":"2023","unstructured":"Baghy, K., Lad\u00e1nyi, A., Reszegi, A. & Kovalszky, I. Insights into the tumor microenvironment\u2014components, functions and therapeutics. Int. J. Mol. Sci. 24(24), 17536 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"85887_CR65","doi-asserted-by":"publisher","first-page":"1295257","DOI":"10.3389\/fimmu.2023.1295257","volume":"14","author":"U Basak","year":"2023","unstructured":"Basak, U. et al. Tumor-associated macrophages: an effective player of the tumor microenvironment. Front. Immunol. 14, 1295257 (2023).","journal-title":"Front. Immunol."},{"key":"85887_CR66","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.2147\/IJGM.S327367","volume":"14","author":"N Sial","year":"2021","unstructured":"Sial, N. et al. Multi-omics analysis identified TMED2 as a shared potential biomarker in six subtypes of human cancer. Int. J. Gen. Med. 14, 7025\u20137042 (2021).","journal-title":"Int. J. Gen. Med."},{"issue":"3","key":"85887_CR67","first-page":"986","volume":"12","author":"M Usman","year":"2022","unstructured":"Usman, M. et al. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers. Am. J. Cancer Res. 12(3), 986 (2022).","journal-title":"Am. J. Cancer Res."},{"issue":"1","key":"85887_CR68","doi-asserted-by":"publisher","first-page":"19873","DOI":"10.1038\/s41598-021-99321-w","volume":"11","author":"N Sial","year":"2021","unstructured":"Sial, N. et al. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes. Sci. Rep. 11(1), 19873 (2021).","journal-title":"Sci. Rep."},{"issue":"2","key":"85887_CR69","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1566524022666220112142409","volume":"23","author":"M Usman","year":"2023","unstructured":"Usman, M. et al. SHMT2 is associated with tumor purity, CD8+\u2009T immune cells infiltration, and a novel therapeutic target in four different human cancers. Curr. Mol. Med. 23(2), 161\u2013176 (2023).","journal-title":"Curr. Mol. Med."},{"issue":"24","key":"85887_CR70","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.3390\/cancers14246255","volume":"14","author":"ML Centomo","year":"2022","unstructured":"Centomo, M. L., Vitiello, M., Poliseno, L. & Pandolfi, P. P. An immunocompetent environment unravels the proto-oncogenic role of miR-22. Cancers 14(24), 6255 (2022).","journal-title":"Cancers"},{"key":"85887_CR71","doi-asserted-by":"publisher","first-page":"786150","DOI":"10.3389\/fonc.2021.786150","volume":"11","author":"E Naakka","year":"2022","unstructured":"Naakka, E. et al. miR-22 and miR-205 drive tumor aggressiveness of mucoepidermoid carcinomas of salivary glands. Front. Oncol. 11, 786150 (2022).","journal-title":"Front. Oncol."},{"issue":"3","key":"85887_CR72","doi-asserted-by":"publisher","first-page":"e0173292","DOI":"10.1371\/journal.pone.0173292","volume":"12","author":"Q-M Ge","year":"2017","unstructured":"Ge, Q-M., Huang, C-M., Zhu, X-Y., Bian, F. & Pan, S-M. Differentially expressed miRNAs in sepsis-induced acute kidney injury target oxidative stress and mitochondrial dysfunction pathways. PLoS One 12(3), e0173292 (2017).","journal-title":"PLoS One"},{"key":"85887_CR73","doi-asserted-by":"publisher","first-page":"596826","DOI":"10.3389\/fgene.2020.596826","volume":"11","author":"Y Lin","year":"2021","unstructured":"Lin, Y. et al. Identification of key MicroRNAs and mechanisms in prostate cancer evolution based on biomarker prioritization model and carcinogenic survey. Front. Genet. 11, 596826 (2021).","journal-title":"Front. Genet."},{"issue":"1","key":"85887_CR74","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1515\/med-2021-0388","volume":"16","author":"L Sun","year":"2021","unstructured":"Sun, L. et al. Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer. Open Med. 16(1), 1705\u20131717 (2021).","journal-title":"Open Med."},{"issue":"2","key":"85887_CR75","doi-asserted-by":"publisher","first-page":"e0281536","DOI":"10.1371\/journal.pone.0281536","volume":"18","author":"S Cui","year":"2023","unstructured":"Cui, S., Chen, Y., Guo, Y., Wang, X. & Chen, D. Hsa-Mir-22-3p inhibits liver cancer cell EMT and cell migration\/invasion by indirectly regulating SPRY2. PLoS One 18(2), e0281536 (2023).","journal-title":"PLoS One"},{"issue":"4","key":"85887_CR76","first-page":"661","volume":"4","author":"A Ashja Ardalan","year":"2024","unstructured":"Ashja Ardalan, A., Khalili-Tanha, G. & Shoari, A. Shaping the landscape of lung cancer: the role and therapeutic potential of matrix metalloproteinases. Int. J. Transl. Med. 4(4), 661\u2013679 (2024).","journal-title":"Int. J. Transl. Med."},{"issue":"21","key":"85887_CR77","doi-asserted-by":"publisher","first-page":"15500","DOI":"10.3390\/ijms242115500","volume":"24","author":"A Bogut","year":"2023","unstructured":"Bogut, A. et al. Galectin-1 in pancreatic ductal adenocarcinoma: bridging tumor biology, immune evasion, and therapeutic opportunities. Int. J. Mol. Sci. 24(21), 15500 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"85887_CR78","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","volume":"137","author":"G Gonzalez-Avila","year":"2019","unstructured":"Gonzalez-Avila, G. et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit. Rev. Oncol. Hematol. 137, 57\u201383 (2019).","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"85887_CR79","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/dvdy.24548","volume":"247","author":"K Drak Alsibai","year":"2018","unstructured":"Drak Alsibai, K. & Meseure, D. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial\u2013mesenchymal transition and cancer metastasis. Dev. Dyn. 247(3), 405\u2013431 (2018).","journal-title":"Dev. Dyn."},{"issue":"6","key":"85887_CR80","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3390\/ijms17060868","volume":"17","author":"P Pittayapruek","year":"2016","unstructured":"Pittayapruek, P., Meephansan, J., Prapapan, O., Komine, M. & Ohtsuki, M. Role of matrix metalloproteinases in photoaging and photocarcinogenesis. Int. J. Mol. Sci. 17(6), 868 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"85887_CR81","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1007\/s00018-011-0763-x","volume":"68","author":"H Hua","year":"2011","unstructured":"Hua, H., Li, M., Luo, T., Yin, Y. & Jiang, Y. Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cell. Mol. Life Sci. 68, 3853\u20133868 (2011).","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85887-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85887-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85887-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T04:18:15Z","timestamp":1737001095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85887-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85887"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85887-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"8 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2152"}}